Monitoring of metabolic adverse events of second-generation antipsychotics in a naive paediatric population followed in mental health outpatient and inpatient clinical settings: MEMAS prospective study protocol

INTRODUCTION: Second-generation antipsychotics (SGAs) are widely used in the paediatric population. It is currently established that SGAs may induce metabolic adverse events (AEs) such as weight gain, perturbation of blood lipids or glucose with risk of potential cardiovascular morbidity and mortali...

Descripción completa

Detalles Bibliográficos
Autores principales: Menard, Marie-Line, Ilies, Drigissa, Abadie, Pascale, Jean-Baptiste, Thaïna, Choquette, Rachel, Huet, Anne-Sophie, Ben Amor, Leila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Research Methods
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813300/
https://www.ncbi.nlm.nih.gov/pubmed/33455928
http://dx.doi.org/10.1136/bmjopen-2020-040764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813300/
https://www.ncbi.nlm.nih.gov/pubmed/33455928
http://dx.doi.org/10.1136/bmjopen-2020-040764

Ejemplares similares